These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1045 related articles for article (PubMed ID: 27449595)

  • 21. Overcoming drug efflux-based multidrug resistance in cancer with nanotechnology.
    Xue X; Liang XJ
    Chin J Cancer; 2012 Feb; 31(2):100-9. PubMed ID: 22237039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade.
    Chen Z; Shi T; Zhang L; Zhu P; Deng M; Huang C; Hu T; Jiang L; Li J
    Cancer Lett; 2016 Jan; 370(1):153-64. PubMed ID: 26499806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The therapeutic potential of targeting ABC transporters to combat multi-drug resistance.
    Bugde P; Biswas R; Merien F; Lu J; Liu DX; Chen M; Zhou S; Li Y
    Expert Opin Ther Targets; 2017 May; 21(5):511-530. PubMed ID: 28335655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
    Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
    Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mouse ATP-Binding Cassette (ABC) Transporters Conferring Multi-Drug Resistance.
    Li S; Zhang W; Yin X; Xing S; Xie HQ; Cao Z; Zhao B
    Anticancer Agents Med Chem; 2015; 15(4):423-32. PubMed ID: 25929575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human ABC transporter ABCG2 in cancer chemotherapy: drug molecular design to circumvent multidrug resistance.
    Ishikawa T; Saito H; Hirano H; Inoue Y; Ikegami Y
    Methods Mol Biol; 2012; 910():267-78. PubMed ID: 22821599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Zafirlukast antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance.
    Sun YL; Kathawala RJ; Singh S; Zheng K; Talele TT; Jiang WQ; Chen ZS
    Anticancer Drugs; 2012 Sep; 23(8):865-73. PubMed ID: 22614107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utilizing non-coding RNA-mediated regulation of ATP binding cassette (ABC) transporters to overcome multidrug resistance to cancer chemotherapy.
    To KKW; Huang Z; Zhang H; Ashby CR; Fu L
    Drug Resist Updat; 2024 Mar; 73():101058. PubMed ID: 38277757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving cancer chemotherapy with modulators of ABC drug transporters.
    Shukla S; Ohnuma S; Ambudkar SV
    Curr Drug Targets; 2011 May; 12(5):621-30. PubMed ID: 21039338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ABC Transporters in the Development of Multidrug Resistance in Cancer Therapy.
    Dlugosz A; Janecka A
    Curr Pharm Des; 2016; 22(30):4705-4716. PubMed ID: 26932159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strategies for overcoming ABC-transporters-mediated multidrug resistance (MDR) of tumor cells.
    Borowski E; Bontemps-Gracz MM; Piwkowska A
    Acta Biochim Pol; 2005; 52(3):609-27. PubMed ID: 16175236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of inhibitors of ATP-binding cassette drug transporters: present status and challenges.
    Shukla S; Wu CP; Ambudkar SV
    Expert Opin Drug Metab Toxicol; 2008 Feb; 4(2):205-23. PubMed ID: 18248313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Advances in the targeting ATP-binding cassette transporters to overcome tumor multi-drug resistance].
    Wei N; Sun H; Liu GT
    Yao Xue Xue Bao; 2010 Oct; 45(10):1205-11. PubMed ID: 21348297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversal of ABC drug transporter-mediated multidrug resistance in cancer cells: evaluation of current strategies.
    Wu CP; Calcagno AM; Ambudkar SV
    Curr Mol Pharmacol; 2008 Jun; 1(2):93-105. PubMed ID: 19079736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tackling multidrug resistance mediated by efflux transporters in tumor-initiating cells.
    McIntosh K; Balch C; Tiwari AK
    Expert Opin Drug Metab Toxicol; 2016 Jun; 12(6):633-44. PubMed ID: 27116192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of ABC transporters in cancer chemotherapy.
    Sun YL; Patel A; Kumar P; Chen ZS
    Chin J Cancer; 2012 Feb; 31(2):51-7. PubMed ID: 22257384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-P-glycoprotein drug export mechanisms of multidrug resistance.
    List AF
    Semin Hematol; 1997 Oct; 34(4 Suppl 5):20-4. PubMed ID: 9408957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carotenoids reverse multidrug resistance in cancer cells by interfering with ABC-transporters.
    Eid SY; El-Readi MZ; Wink M
    Phytomedicine; 2012 Aug; 19(11):977-87. PubMed ID: 22770743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parguerenes: Marine red alga bromoditerpenes as inhibitors of P-glycoprotein (ABCB1) in multidrug resistant human cancer cells.
    Huang XC; Sun YL; Salim AA; Chen ZS; Capon RJ
    Biochem Pharmacol; 2013 May; 85(9):1257-68. PubMed ID: 23415901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 53.